PURE Bioscience, Inc.

PURE · OTC Markets OTCQB · Stock · Consumer Defensive
$0.08
-0.13% today
Delayed price,

What PURE Bioscience does

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company's technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.

Key facts

Sector
Consumer Defensive
Industry
Household & Personal Products
Market cap
$10.4M
P/E (ttm)
—
Forward P/E
—
Dividend yield
0.00%
Beta
0.32
Profit margin
-91.0%
Employees
11
Headquarters
El Cajon, CA, United States
Exchange
OTC Markets OTCQB

Performance

1 Month
+14.1%
3 Months
+33.2%
6 Months
+33.2%
1 Year
-0.1%
5 Years
-75.8%
$0.0452-week range$0.10
Biggest setback — last 12 months
-50.0%
13 Oct 2025 → 29 Dec 2025
Fell from $0.08 to $0.04 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+150.0%
29 Dec 2025 → 30 Mar 2026
Ran from $0.04 to $0.10 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$0.05 (-35.2%)$0.08$0.12 (+54.2%)
3 Months$0.04 (-52.8%)$0.08$0.17 (+111.6%)
6 Months$0.03 (-65.3%)$0.08$0.23 (+188.9%)
12 Months$0.02 (-77.7%)$0.08$0.36 (+348.2%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 150.0%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent insider activity

Acquired 155,000 shares — Myers Thomas Richard, Exec VP, Tech & Development · 2024-08-22
Acquired 125,000 shares — Rendall David, Director · 2024-08-22
Acquired 125,000 shares — Blotner Bernard, Director · 2024-08-22
Acquired 155,000 shares — Elliott Mark Stuart, Vice President, Finance · 2024-08-22
Acquired 125,000 shares — Lee Tom Y, Director · 2024-08-22
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.